Please provide your email address to receive an email when new articles are posted on . Welcome to another edition of CEDARS/ASPENS Debates. CEDARS/ASPENS is a society of cornea, cataract and ...
A clinical trial led by Kirby Institute at UNSW Sydney has found that point-of-care testing for hepatitis B DNA is as ...
Point of care testing in the emergency department: Finding comprehensive solutions that work for you
Speed and precision are two of the most vital considerations when it comes to patient care in the high-stakes environment of the Emergency Department (ED). Thus, swift decision-making and accurate ...
Please provide your email address to receive an email when new articles are posted on . Point-of-care saliva testing can detect HIV in 20 minutes. HIV testing rates jumped from 12% to 55% at a clinic ...
A NEW point-of-care fingerstick test detects hepatitis B virus (HBV) within one hour, a 2026 diagnostic study has found. The ...
Genetic testing for hereditary cancers, such as breast, colon, pancreatic, and ovarian cancer, helps at-risk individuals understand their familial risk for these diseases and make informed decisions ...
Salvatore Viscomi MD, co-founder of Carna Health is an entrepreneur with a passion for digital health and remote patient monitoring. The Covid-19 pandemic taught us that providing care outside of ...
Point-of-care testing (POCT) includes professional-grade in vitro diagnostic tests completed in close proximity to patients. By performing diagnostic tests closer to patients and obtaining results ...
A clinical trial led by Kirby Institute at UNSW Sydney has found that point-of-care testing for hepatitis B DNA is as effective as traditional laboratory testing, paving the way for faster diagnosis ...
Large scale deployment of rapid, low-cost, hand-held point of care testing devices for diagnosing infectious diseases is critical for improving global health. Recent advances in engineering and ...
Point of care devices within the healthcare system can aid in improving diagnoses as well as the control of diseases through monitoring. These devices can include glucose monitors that only require a ...
LONDON--(BUSINESS WIRE)--The global point-of-care coagulation testing market is poised to grow by USD 1 billion during 2020-2024, progressing at a CAGR of over 6% during the forecast period. Request ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results